Matches in Wikidata for { <http://www.wikidata.org/entity/Q57580518> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q57580518 description "im Oktober 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57580518 description "wetenschappelijk artikel" @default.
- Q57580518 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q57580518 name "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 name "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 type Item @default.
- Q57580518 label "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 label "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 prefLabel "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 prefLabel "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 P1433 Q57580518-85150B86-D063-46E9-8EF1-F4A9A26390C1 @default.
- Q57580518 P1476 Q57580518-5EAF31BB-A56F-47CD-90B7-06F330AC8B2E @default.
- Q57580518 P2093 Q57580518-048663F1-DDD8-4811-A719-9D809DECBD24 @default.
- Q57580518 P2093 Q57580518-04EBB94F-9593-42A3-9B32-24544A078ADC @default.
- Q57580518 P2093 Q57580518-2F0A8FDD-7032-435E-837D-DDF509F1A4EF @default.
- Q57580518 P2093 Q57580518-4405C7C5-EEEB-4601-9B2D-97ACF168CEC7 @default.
- Q57580518 P2093 Q57580518-D016416A-ED78-4632-A922-EC93951ACF79 @default.
- Q57580518 P2093 Q57580518-D3F5A8FA-949F-4EB7-9457-8F33CFF1D9D5 @default.
- Q57580518 P31 Q57580518-835FEDA3-5743-4AEE-9E2A-CF221541DE85 @default.
- Q57580518 P356 Q57580518-D4F2E8CD-4E68-4202-B337-B66BD2D57814 @default.
- Q57580518 P433 Q57580518-BDFD1808-50C0-46C4-BECA-CF22B709F68D @default.
- Q57580518 P478 Q57580518-61C07C10-3804-48B6-B433-4710B59A656E @default.
- Q57580518 P577 Q57580518-C4A04D51-18D4-42E9-9F0C-80A0F9EBECC5 @default.
- Q57580518 P921 Q57580518-4AE39B10-FEA7-435D-92A6-875636896C3B @default.
- Q57580518 P921 Q57580518-58036E1D-F6B3-4A2C-AE67-49EBD9CFD610 @default.
- Q57580518 P921 Q57580518-5C1FF236-0BA3-4B0E-8416-EBC55E9F28A1 @default.
- Q57580518 P921 Q57580518-F044A38F-D4BC-4378-91AE-54CA59F505DC @default.
- Q57580518 P356 MDW365.91 @default.
- Q57580518 P1433 Q326122 @default.
- Q57580518 P1476 "A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)" @default.
- Q57580518 P2093 "A. Wardley" @default.
- Q57580518 P2093 "D. Cameron" @default.
- Q57580518 P2093 "G. Curigliano" @default.
- Q57580518 P2093 "S. Loibl" @default.
- Q57580518 P2093 "V. Müller" @default.
- Q57580518 P2093 "X. Pivot" @default.
- Q57580518 P31 Q13442814 @default.
- Q57580518 P356 "10.1093/ANNONC/MDW365.91" @default.
- Q57580518 P433 "suppl_6" @default.
- Q57580518 P478 "27" @default.
- Q57580518 P577 "2016-10-01T00:00:00Z" @default.
- Q57580518 P921 Q18555947 @default.
- Q57580518 P921 Q269829 @default.
- Q57580518 P921 Q412616 @default.
- Q57580518 P921 Q420207 @default.